Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,658 | -10,462 | -7,759 | -5,324 | -2,706 |
| Depreciation Amortization | 13 | 3,269 | 2,320 | 1,421 | 577 |
| Accounts receivable | N/A | 21 | 24 | 13 | 25 |
| Other Working Capital | 278 | 329 | -43 | -170 | 168 |
| Other Operating Activity | -2,658 | 904 | 840 | 678 | 300 |
| Operating Cash Flow | $-709 | $-5,939 | $-4,618 | $-3,382 | $-1,636 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,100 | N/A | N/A | N/A | N/A |
| Debt Repayment | -11 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 6,000 | 4,500 | 3,500 | 1,500 |
| Financing Cash Flow | $10,089 | $6,000 | $4,500 | $3,500 | $1,500 |
| Beginning Cash Position | 532 | 634 | 634 | 634 | 634 |
| End Cash Position | 9,912 | 695 | 516 | 752 | 498 |
| Net Cash Flow | $9,380 | $61 | $-118 | $118 | $-136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -709 | -5,939 | -4,618 | -3,382 | -1,636 |
| Free Cash Flow | -709 | -5,939 | -4,618 | -3,382 | -1,636 |